Daniel Griffin updates the clinical situation with COVID-19 patients, followed by analysis of the remedesivir clinical trial results, and answers listener questions.

Hosts:Vincent RacanielloandRich Condit

Guest:Daniel Griffin

https://www.microbe.tv/twiv/

Click arrow to play:

Links for this episode

• Pulmonary embolism in COVID-19 (Emerg Inf Dis) 9:03
• Patch Study 11:43
• Remdesivir in adults with severe COVID-19 (Lancet) 22:31
• ACTT remdesivir trial (NIAID) 34:44
• Commentary on remdesivir trials (Lancet) 28:22
• FDA expected to issue remdesivir EUA (Contagion Live) 39:03
• Recovered COVID-19 patients wrong (Korea Herald) 40:33
• Letters read on TWiV 608 45:24
• Image credit
• Timestamps by Jolene. Thanks!